Skip to main content

Choroidal thickness measurements during central serous chorioretinopathy treatment

International Ophthalmology volume 34, pages 7–13 (2014)Cite this article

Abstract

To determine changes in choroidal thickness in patients with central serous chorioretinopathy (CSCR) during the first 3 months after initial diagnosis and assess variable therapeutic interventions via enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT). In this prospective study, choroidal thickness was measured via EDI-OCT both in the affected and fellow eyes of 10 patients with CSCR at the fovea, as well as at 500 and 1,000 μm both temporal and nasal from the centre of the fovea and at the leakage point (if present), visualised via fluorescein angiography. Follow-up measurements were performed after 2–3 weeks, 6–8 weeks and 3 months. Seven of the 10 patients received additional systemic therapy with oral acetazolamide. A control group of eight healthy subjects was recruited to determine normal choroidal thickness in healthy eyes. The mean age of the 10 patients (9 male, 1 female) in the CSCR group was 42.1 (±9.3) years. The choroid in the affected eyes was significantly thickened at baseline compared to fellow eyes and the eyes of healthy subjects. The choroid in the fellow eyes also revealed a slight thickening at baseline compared to normal eyes. During the 3 month follow-up period, the choroidal thickness of the affected eyes showed a highly significant decrease, but did not reach normal levels. Minor changes could also be observed in the fellow eyes but did not reach statistical significance. In patients with CSCR, the average choroidal thickness not only demonstrated a significant thickening at baseline, but also showed a marked decrease after 3 months, yet not reaching normal levels. Our data indicate that after 3 months, normalisation of choroidal thickness is not yet completed.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Ross A, Ross AH, Mohamed Q (2011) Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 22:166–173

    PubMed  Article  Google Scholar 

  2. Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T (2011) Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 31:1603–1608

    PubMed  Article  Google Scholar 

  3. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S (2004) Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 111:244–249

    PubMed  Article  Google Scholar 

  4. Prunte C (1995) Indocyanine green angiographic findings in central serous chorioretinopathy. Int Ophthalmol 19:77–82

    CAS  PubMed  Article  Google Scholar 

  5. van Velthoven ME, Verbraak FD, Garcia PM, Schlingemann RO, Rosen RB, de Smet MD (2005) Evaluation of central serous retinopathy with en face optical coherence tomography. Br J Ophthalmol 89:1483–1488

    PubMed  Article  Google Scholar 

  6. Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF (2010) Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792–1799

    PubMed  Article  Google Scholar 

  7. Pikkel J, Beiran I, Ophir A, Miller B (2002) Acetazolamide for central serous retinopathy. Ophthalmology 109:1723–1725

    PubMed  Article  Google Scholar 

  8. Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147:811–815

    PubMed  Article  Google Scholar 

  9. Spaide RF, Koizumi H, Pozzoni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146:496–500

    PubMed  Article  Google Scholar 

  10. Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29:1469–1473

    PubMed  Article  Google Scholar 

  11. Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 148:445–450

    PubMed  Article  Google Scholar 

  12. Spaide RF (2009) Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 147:644–652

    PubMed  Article  Google Scholar 

  13. Spaide RF (2009) Age-related choroidal atrophy. Am J Ophthalmol 147:801–810

    PubMed  Article  Google Scholar 

  14. Imamura Y, Fujiwara T, Spaide RF (2010) Frequency of glaucoma in central serous chorioretinopathy: a case-control study. Retina 30:267–270

    PubMed  Article  Google Scholar 

  15. Chhablani J, Barteselli G, Wang H, El-Emam S, Kozak I, Doede AL, Bartsch DU, Cheng L, Freeman WR (2012) Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci 53:2274–2280

    PubMed  Article  Google Scholar 

  16. Gass JD (1967) Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 63:139

    Google Scholar 

  17. Iida T, Kishi S, Hagimura N, Shimizu K (1999) Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 19:508–512

    CAS  PubMed  Article  Google Scholar 

  18. Spaide RF, Goldbaum M, Wong DW, Tang KC, Iida T (2003) Serous detachment of the retina. Retina 23:820–846

    PubMed  Article  Google Scholar 

  19. Piccolino FC, Borgia L (1994) Central serous chorioretinopathy and indocyanine green angiography. Retina 14:231–242

    CAS  PubMed  Article  Google Scholar 

  20. Negi A, Marmor MF (1984) Experimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol 102:445–449

    CAS  PubMed  Article  Google Scholar 

  21. Cox SN, Hay E, Bird AC (1988) Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 106:1190–1195

    CAS  PubMed  Article  Google Scholar 

  22. Tripathi RC, Fekrat S, Tripathi BJ, Ernest JT (1991) A direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy. Ann Ophthalmol 23:127–129

    CAS  PubMed  Google Scholar 

  23. Wolfensberger TJ (1999) The role of carbonic anhydrase inhibitors in the management of macular edema. Doc Ophthalmol 97:387–397

    CAS  PubMed  Article  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Affiliations

  1. Department of Ophthalmology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany

    Caroline Brandl, H. Helbig & M. A. Gamulescu

Authors
  1. Caroline Brandl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Helbig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. Gamulescu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caroline Brandl.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Brandl, C., Helbig, H. & Gamulescu, M.A. Choroidal thickness measurements during central serous chorioretinopathy treatment. Int Ophthalmol 34, 7–13 (2014). https://doi.org/10.1007/s10792-013-9774-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-013-9774-y

Keywords

  • Central serous chorioretinopathy (CSCR)
  • EDI-OCT
  • Choroidal thickness